Summary

Eligibility
for people ages 18-80 (full criteria)
Location
at San Francisco, California and other locations
Dates
study started
estimated completion
Principal Investigator
by Daniel Cooke
Headshot of Daniel Cooke
Daniel Cooke

Description

Summary

The purpose of this study is to gather preliminary safety and effectiveness data on Citadel Embolization Device in the treatment of wide-neck intracranial aneurysms.

Official Title

The Citadel Embolization Device Study

Details

In this study, use of the Citadel Embolization Device will be limited to a population of patients with unruptured or ruptured wide-neck aneurysms who meet all study eligibility criteria. The Citadel Embolization Device is intended to endovascularly obstruct or occlude blood flow in intracranial aneurysms.

Keywords

Unruptured Wide-neck Aneurysms, Aneurysm, Citadel Embolization Device

Eligibility

You can join if…

Open to people ages 18-80

  1. Has a single, unruptured or ruptured target intracranial aneurysm that is suitable for endovascular treatment.

You CAN'T join if...

1.Target aneurysm has been previously treated

Locations

  • UCSF
    San Francisco California 94143 United States
  • California Pacific Medical Center
    San Francisco California 94019 United States

Lead Scientist at UCSF

  • Daniel Cooke
    Daniel Cooke, MD, is an Associate Professor in Residence of Neuro Interventional Radiology in the Department of Radiology and Biomedical Imaging at the University of California, San Francisco. His expertise is in ischemic and hemorrhagic stroke, vascular malignancies of the central nervous system, arteriovenous malformations (AVM), arteriovenous fistula (AVF), and aneurysms of the brain and spine.

Details

Status
accepting new patients by invitation only
Start Date
Completion Date
(estimated)
Sponsor
Stryker Neurovascular
ID
NCT04057352
Study Type
Interventional
Participants
Expecting 150 study participants
Last Updated